BBOT BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc. (BBOT) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors Growth Healthcare | Sold Out | -868.2K | -100.0% | $6.6M | 0.0% | 62 |
| TWO SIGMA INVESTMENTS, LP Quant | New | +26.5K | — | $201.8K | 0.0% | 57 |
| Qube Research & Technologies Ltd Quant | Sold Out | -71.9K | -100.0% | $548.1K | 0.0% | 55 |
| Woodline Partners LP Long/Short | Sold Out | -103.7K | -100.0% | $790.2K | 0.0% | 54 |
| Hudson Bay Capital Management Event | Sold Out | -110.0K | -100.0% | $838.2K | 0.0% | 53 |
| Quadrature Capital Quant | Sold Out | -13.4K | -100.0% | $101.7K | 0.0% | 52 |
| ExodusPoint Capital Management Long/Short Quant | Sold Out | -48.1K | -100.0% | $366.7K | 0.0% | 52 |
| Schonfeld Strategic Advisors Long/Short Quant | New | +11.5K | — | $87.7K | 0.0% | 51 |
| Boothbay Fund Management | Sold Out | -80.9K | -100.0% | $616.3K | 0.0% | 49 |
| Aquatic Capital Management Quant | Sold Out | -11.8K | -100.0% | $89.9K | 0.0% | 48 |
Most significant buyers
By move score, not size.
- TWO SIGMA INVESTMENTS, LP
- Schonfeld Strategic Advisors
- Brevan Howard Capital Management
- Armistice Capital
- CITADEL ADVISORS LLC
Most significant sellers
By move score, not size.
- Paradigm BioCapital Advisors
- Qube Research & Technologies Ltd
- Woodline Partners LP
- Hudson Bay Capital Management
- Quadrature Capital
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors | 1 | 0 | 868.2K | -868.2K | -100.0% | 0.0% | Sold Out | 62 |
| TWO SIGMA INVESTMENTS, LP | 2 | 26.5K | 0 | +26.5K | — | 0.0% | New | 57 |
| Qube Research & Technologies Ltd | 2 | 0 | 71.9K | -71.9K | -100.0% | 0.0% | Sold Out | 55 |
| Woodline Partners LP | 2 | 0 | 103.7K | -103.7K | -100.0% | 0.0% | Sold Out | 54 |
| Hudson Bay Capital Management | 3 | 0 | 110.0K | -110.0K | -100.0% | 0.0% | Sold Out | 53 |
| Quadrature Capital | 3 | 0 | 13.4K | -13.4K | -100.0% | 0.0% | Sold Out | 52 |
| ExodusPoint Capital Management | 3 | 0 | 48.1K | -48.1K | -100.0% | 0.0% | Sold Out | 52 |
| Schonfeld Strategic Advisors | 3 | 11.5K | 0 | +11.5K | — | 0.0% | New | 51 |
| Boothbay Fund Management | 4 | 0 | 80.9K | -80.9K | -100.0% | 0.0% | Sold Out | 49 |
| Aquatic Capital Management | 4 | 0 | 11.8K | -11.8K | -100.0% | 0.0% | Sold Out | 48 |
| Brevan Howard Capital Management | 3 | 88.9K | 14.2K | +74.6K | +523.9% | 0.0% | Increased | 43 |
| MILLENNIUM MANAGEMENT LLC | 2 | 105.5K | 266.0K | -160.5K | -60.3% | 0.0% | Reduced | 43 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 58.6K | 101.9K | -43.3K | -42.5% | 0.0% | Reduced | 38 |
| Squarepoint Ops LLC | 2 | 19.7K | 43.2K | -23.5K | -54.5% | 0.0% | Reduced | 37 |
| Armistice Capital | 3 | 1.8M | 1.3M | +436.0K | +32.8% | 0.4% | Increased | 34 |
| CITADEL ADVISORS LLC | 1 | 2.6M | 2.5M | +89.1K | +3.5% | 0.0% | Increased | 28 |
| Deerfield Management | 1 | 4.9M | 4.9M | 0 | +0.0% | 0.5% | Unchanged | 28 |
| EcoR1 Capital | 2 | 2.8M | 2.8M | 0 | +0.0% | 1.1% | Unchanged | 24 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 400.0K | 400.0K | 0 | +0.0% | 0.0% | Unchanged | 20 |
| Moore Capital Management | 3 | 100.0K | 100.0K | 0 | +0.0% | 0.0% | Unchanged | 16 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.